Atherosclerotic involvement of coronary branch vessels

Atherosclerosis
|June 1, 1986
PubMed

Insights

Atherosclerosis affects coronary branch vessels in adults, with plaques often showing severe narrowing despite underdeveloped features. This highlights the complexity of assessing coronary artery disease (CAD) severity.

Area of Science:

  • Cardiovascular Pathology
  • Atherosclerosis Research
  • Coronary Artery Disease

Background:

  • Atherosclerosis commonly affects major coronary arteries.
  • The involvement of smaller coronary branch vessels is less understood.
  • Early detection and characterization of coronary artery disease (CAD) are crucial.

Purpose of the Study:

  • To investigate the prevalence and characteristics of atherosclerotic involvement in coronary branch vessels.
  • To compare atherosclerotic lesions in branch vessels versus major coronary arteries.
  • To assess the stenotic severity in coronary branch vessels.

Main Methods:

  • Post-mortem examination of coronary arteries from 450 healthy individuals (aged 11-55) who died accidentally.
  • Histopathological analysis of atherosclerotic plaques, fatty streaks, intimal necrotic areas, and microthrombi.
  • Quantification of lumen reduction in both major and branch coronary arteries.

Main Results:

  • In subjects aged 35-55, 1 in 3 with major coronary artery plaques also had branch vessel plaques.
  • Fatty streaks, intimal necrotic areas, and microthrombi were also found in branch vessels.
  • Significant lumen reduction (>50%) was more common in branch vessels (1 in 6 subjects aged 51-55) than major arteries.
  • 8.2% showed more severe stenosis in branch vessels than major arteries.
  • Branch vessel plaques were 'underdeveloped' but often severely stenotic (>75% lumen reduction).

Conclusions:

  • Atherosclerotic involvement of coronary branch vessels is common in adults.
  • Lesions in branch vessels can be severely stenotic despite immature plaque morphology.
  • The clinical significance of coronary stenosis requires consideration of collateral circulation.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...